Prevention and treatment of recurrent Clostridioides difficile infection

Current Opinion in Infectious Diseases
Jae Hyun Shin, Cirle A Warren

Abstract

Clostridioides difficile infection (CDI) is a significant burden on the health system, especially due to high recurrence rates. Since the beginning of the CDI epidemic in early 2000s, many strategies for combatting recurrence have been explored, with moderate success so far. This review will focus on the most recent developments in recurrent CDI prevention and treatment. There are two main mechanisms of CDI recurrence: alteration in microbiome and poor antibody response. Development of new antibiotics aims to minimize damage to the microbiome. Fecal transplant or other microbiome replacement therapies seek to replenish the missing elements in the microbiome. Fecal microbiota transplant is the most effective treatment for prevention of CDI recurrenceso far, but is difficult to standardize and regulate, leading to efforts to develop microbiome-derived therapeutics. A deficiency in developing antibodies to C. difficile toxins is another mechanism of recurrence. Active immunization using toxoid vaccines or passive immunization using mAbs address this aspect. There are promising new treatments for recurrent CDI in development. Fecal microbiota transplant remains the most effective therapy for multiply recurrent CDI. New antibiotics,...Continue Reading

References

Mar 9, 1978·The New England Journal of Medicine·J G BartlettA B Onderdonk
Apr 2, 1998·The Journal of Hospital Infection·M H WilcoxA Davidson
Oct 26, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M SurawiczG W Elmer
Mar 31, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Carlene A MutoLee H Harrison
Jan 18, 2008·The Journal of Infectious Diseases·Ju Young ChangVincent B Young
Jan 15, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Scott R CurryLee H Harrison
Jan 22, 2010·The New England Journal of Medicine·Israel LowyDonna M Ambrosino
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Mary C ReaR Paul Ross
Feb 4, 2011·The New England Journal of Medicine·Thomas J LouieUNKNOWN OPT-80-003 Clinical Study Group
Aug 17, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kathleen M MullaneSherwood L Gorbach
Oct 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mini KambojKent A Sepkowitz
Jul 7, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oliver A CornelySherwood L Gorbach
Jan 18, 2013·The New England Journal of Medicine·Els van NoodJosbert J Keller
Mar 30, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Paul M StrangesCurtis D Collins
May 25, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sarah M BartschBruce Y Lee
May 30, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oliver A CornelySherwood Gorbach
Apr 3, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gauree G KonijetiAshwin N Ananthakrishnan
Aug 7, 2014·The Journal of Antimicrobial Chemotherapy·Dilip NathwaniIsaac A O Odeyemi
Feb 26, 2015·The New England Journal of Medicine·Fernanda C LessaL Clifford McDonald
Apr 16, 2015·The New England Journal of Medicine·Daniel A Leffler, J Thomas Lamont
Apr 30, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Lynne V McFarland
Jun 7, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A DalhoffC E Nord
Nov 14, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert OrensteinUNKNOWN PUNCH CD Investigators
Feb 26, 2016·The Journal of Infectious Diseases·Sahil KhannaElizabeth L Hohmann
Sep 14, 2016·The American Journal of Gastroenterology·Alex CarignanJacques Pépin
Jul 6, 2015·Journal of Law and the Biosciences·Rachel E Sachs, Carolyn A Edelstein
Dec 24, 2016·Journal of Clinical Gastroenterology·Clayton M SpicelandDarrell S Pardi
Dec 25, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susy S HotaSusan M Poutanen
Jan 6, 2017·Antimicrobial Agents and Chemotherapy·John F Kokai-KunJoseph Sliman
Jan 26, 2017·The New England Journal of Medicine·Mark H WilcoxUNKNOWN MODIFY I and MODIFY II Investigators
Jan 29, 2017·The Lancet Infectious Diseases·Kate E DingleUNKNOWN Modernising Medical Microbiology Informatics Group
Jun 8, 2017·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Benjamin D SirbuStuart Johnson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacteriotherapy

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Bacteriotherapy (ASM)

Bacteriotherapy, also known as fecal transplantation, involves the transfer of stool from a healthy donor into the gastrointestinal tract for the purpose of treating recurrent C. difficile colitis. Here is the latest on bacteriotherapy.

Related Papers

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
Cole KrenskySusy S Hota
Expert Opinion on Emerging Drugs
Giovanni CammarotaMassimo Montalto
The American Journal of Gastroenterology
Amar MandaliaTanvi Dhere
© 2021 Meta ULC. All rights reserved